Tokyo Tape
Sign in
← Nipro

Quarterly report · Q1

8086.TEDINET S100OZ7P
Period2022-04-01 → 2022-06-30
Filed2022-08-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥127.9bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥494.8bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥118.0bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥3.0bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥5.5bn2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥7.3bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥27.6bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥5.2bn2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥9.0bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥5.3bn2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥5.3bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥13.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥3.3bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥5.7bn2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥3.5bn2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥947.6bnat 2022-06-30Cons.Assets
Total assets¥930.3bnat 2022-03-31Cons.Assets
Total assets¥874.8bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥730.3bnat 2022-06-30Cons.Liabilities
Total liabilities¥730.5bnat 2022-03-31Cons.Liabilities
Net assets / equity¥217.3bnat 2022-06-30Cons.Net assets
Net assets / equity¥199.9bnat 2022-03-31Cons.Net assets
Net assets / equity¥185.9bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥84.7bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥95.3bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥32.352022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥82.52021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥20.242021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥28.662022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥77.422021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
Equity ratio21.3%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio19.9%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio19.8%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 54
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥1.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥154m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥855m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30¥211m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥9.3bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥9.3bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥7.1bn
jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segmentrevenue2022-04-01 → 2022-06-30¥99.3bn
jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segmentrevenue external2022-04-01 → 2022-06-30¥97.7bn
jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥1.6bn
jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segmentsegment profit2022-04-01 → 2022-06-30¥8.5bn
jpcrp040300-q1r_E02688-000Medicine Relatedreportable segmentrevenue2022-04-01 → 2022-06-30¥23.2bn
jpcrp040300-q1r_E02688-000Medicine Relatedreportable segmentrevenue external2022-04-01 → 2022-06-30¥17.9bn
jpcrp040300-q1r_E02688-000Medicine Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥5.3bn
jpcrp040300-q1r_E02688-000Medicine Relatedreportable segmentsegment profit2022-04-01 → 2022-06-30¥407m
jpcrp040300-q1r_E02688-000Pharma Packagingreportable segmentrevenue2022-04-01 → 2022-06-30¥13.7bn
jpcrp040300-q1r_E02688-000Pharma Packagingreportable segmentrevenue external2022-04-01 → 2022-06-30¥12.2bn
jpcrp040300-q1r_E02688-000Pharma Packagingreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥1.5bn
jpcrp040300-q1r_E02688-000Pharma Packagingreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.0bn
—segment totalrevenue2022-04-01 → 2022-06-30¥136.2bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥127.7bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥8.4bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥9.9bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥137.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥127.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥9.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥10.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-06-30¥693m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-06-30¥153m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-06-30¥540m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-06-30¥145m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥8.8bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥8.8bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥5.6bn
jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segmentrevenue2021-04-01 → 2021-06-30¥92.2bn
jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segmentrevenue external2021-04-01 → 2021-06-30¥90.6bn
jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥1.5bn
jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segmentsegment profit2021-04-01 → 2021-06-30¥9.5bn
jpcrp040300-q1r_E02688-000Medicine Relatedreportable segmentrevenue2021-04-01 → 2021-06-30¥21.5bn
jpcrp040300-q1r_E02688-000Medicine Relatedreportable segmentrevenue external2021-04-01 → 2021-06-30¥16.4bn
jpcrp040300-q1r_E02688-000Medicine Relatedreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥5.1bn
jpcrp040300-q1r_E02688-000Medicine Relatedreportable segmentsegment profit2021-04-01 → 2021-06-30¥587m
jpcrp040300-q1r_E02688-000Pharma Packagingreportable segmentrevenue2021-04-01 → 2021-06-30¥12.4bn
jpcrp040300-q1r_E02688-000Pharma Packagingreportable segmentrevenue external2021-04-01 → 2021-06-30¥10.8bn
jpcrp040300-q1r_E02688-000Pharma Packagingreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥1.6bn
jpcrp040300-q1r_E02688-000Pharma Packagingreportable segmentsegment profit2021-04-01 → 2021-06-30¥844m
—segment totalrevenue2021-04-01 → 2021-06-30¥126.1bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥117.8bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥8.2bn
—segment totalsegment profit2021-04-01 → 2021-06-30¥10.9bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-06-30¥126.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-06-30¥118.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-06-30¥8.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-06-30¥11.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 442
ItemContextValueUnit
Extraordinary lossCurrentYTDDuration277000000JPY
Income before income taxesPrior1YTDDuration5288000000JPY
Income before income taxesCurrentYTDDuration9008000000JPY
Income taxes currentPrior1YTDDuration977000000JPY
Income taxes currentCurrentYTDDuration2459000000JPY
Income taxes deferredPrior1YTDDuration771000000JPY
Income taxes deferredCurrentYTDDuration807000000JPY
Income taxesPrior1YTDDuration1749000000JPY
Income taxesCurrentYTDDuration3267000000JPY
Profit lossPrior1YTDDuration3539000000JPY
Profit lossCurrentYTDDuration5741000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration239000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration466000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration3300000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration5275000000JPY
Profit lossPrior1YTDDuration3539000000JPY
Profit lossCurrentYTDDuration5741000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration401000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-875000000JPY
Deferred gains or losses on hedges net of tax ociPrior1YTDDuration14000000JPY
Deferred gains or losses on hedges net of tax ociCurrentYTDDuration6000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration11705000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration13847000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-24000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-15000000JPY
Share of other comprehensive income of associates accounted for using equity method ociPrior1YTDDuration118000000JPY
Share of other comprehensive income of associates accounted for using equity method ociCurrentYTDDuration778000000JPY
Other comprehensive incomePrior1YTDDuration12214000000JPY
Other comprehensive incomeCurrentYTDDuration13741000000JPY
Comprehensive incomePrior1YTDDuration15754000000JPY
Comprehensive incomeCurrentYTDDuration19483000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration15330000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration18717000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration424000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration765000000JPY
Exporting notes receivable discountedPrior1YearInstant4000000JPY
Exporting notes receivable discountedCurrentQuarterInstant－JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E02688-000MedicalTreatmentRelatedReportableSegmentsMember90638000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E02688-000MedicineRelatedReportableSegmentsMember16388000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E02688-000PharmaPackagingReportableSegmentMember10821000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember117847000000JPY
Revenues from external customersPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember153000000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember118001000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration118001000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E02688-000MedicalTreatmentRelatedReportableSegmentsMember1523000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E02688-000MedicineRelatedReportableSegmentsMember5096000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E02688-000PharmaPackagingReportableSegmentMember1600000000JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember8220000000JPY
Transactions with other segmentsPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember540000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass